Protagenic adds ex-bluebird executive as PT00114 moves toward Phase 2 - Stock Titan4 weeks ago • Google News
Protagenic biotech gains OTCQB listing as depression drug nears Phase 2 - Stock Titan2026-03-10 • Google News
Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice - ACCESS Newswire2025-11-27 • Google News